Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: a nationwide cohort study

Mia-Louise Nielsen; David Thein; Mads Kirchheiner Rasmussen; Trine Bertelsen; Tomas Norman Dam; Lone Skov; Lars Erik Bryld; Jashin J Wu; Simon Francis Thomsen; Jacob P Thyssen; Alexander Egeberg

doi:10.1016/j.jaad.2023.01.029

Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: a nationwide cohort study

Mia-Louise Nielsen^*, David Thein, Mads Kirchheiner Rasmussen, Trine Bertelsen, Tomas Norman Dam, Lone Skov, Lars Erik Bryld, Jashin J Wu, Simon Francis Thomsen, Jacob P Thyssen, Alexander Egeberg

^*Corresponding author for this work

Department of Clinical Medicine - The Department of Dermatology and Venereology

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

4 Citations (Scopus)

7 Downloads (Pure)

Original language	English
Journal	Journal of the American Academy of Dermatology
Volume	88
Issue	6
Pages (from-to)	1378-1381
Number of pages	4
ISSN	0190-9622
DOIs	https://doi.org/10.1016/j.jaad.2023.01.029
Publication status	Published - Jun 2023

Keywords

PASI
biologics
psoriasis
remission
skin clearance
systemics
topicals
treatment discontinuation

Access to Document

10.1016/j.jaad.2023.01.029Licence: CC BY

1-s2.0-S0190962223001652-mainFinal published version, 144 KBLicence: CC BY

Cite this

Nielsen, M.-L., Thein, D., Rasmussen, M. K., Bertelsen, T., Dam, T. N., Skov, L., Bryld, L. E., Wu, J. J., Thomsen, S. F., Thyssen, J. P., & Egeberg, A. (2023). Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: a nationwide cohort study. Journal of the American Academy of Dermatology, 88(6), 1378-1381. https://doi.org/10.1016/j.jaad.2023.01.029

@article{ea713dc86f1644f28095be53271aaf3a,

title = "Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: a nationwide cohort study",

keywords = "PASI, biologics, psoriasis, remission, skin clearance, systemics, topicals, treatment discontinuation",

author = "Mia-Louise Nielsen and David Thein and Rasmussen, {Mads Kirchheiner} and Trine Bertelsen and Dam, {Tomas Norman} and Lone Skov and Bryld, {Lars Erik} and Wu, {Jashin J} and Thomsen, {Simon Francis} and Thyssen, {Jacob P} and Alexander Egeberg",

note = "Funding Information: We acknowledge the substantial contribution of the academic hospitals and private clinics and their physicians that report data to DERMBIO.",

year = "2023",

month = jun,

doi = "10.1016/j.jaad.2023.01.029",

language = "English",

volume = "88",

pages = "1378--1381",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Elsevier Inc.",

number = "6",

}

Nielsen, M-L, Thein, D, Rasmussen, MK, Bertelsen, T, Dam, TN, Skov, L, Bryld, LE, Wu, JJ, Thomsen, SF, Thyssen, JP & Egeberg, A 2023, 'Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: a nationwide cohort study', Journal of the American Academy of Dermatology, vol. 88, no. 6, pp. 1378-1381. https://doi.org/10.1016/j.jaad.2023.01.029

Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis: a nationwide cohort study. / Nielsen, Mia-Louise; Thein, David; Rasmussen, Mads Kirchheiner et al.
In: Journal of the American Academy of Dermatology, Vol. 88, No. 6, 06.2023, p. 1378-1381.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review

TY - JOUR

T1 - Trajectories and prognosis after discontinuation of biologics due to remission in psoriasis

T2 - a nationwide cohort study

AU - Nielsen, Mia-Louise

AU - Thein, David

AU - Rasmussen, Mads Kirchheiner

AU - Bertelsen, Trine

AU - Dam, Tomas Norman

AU - Skov, Lone

AU - Bryld, Lars Erik

AU - Wu, Jashin J

AU - Thomsen, Simon Francis

AU - Thyssen, Jacob P

AU - Egeberg, Alexander

N1 - Funding Information: We acknowledge the substantial contribution of the academic hospitals and private clinics and their physicians that report data to DERMBIO.

PY - 2023/6

Y1 - 2023/6

KW - PASI

KW - biologics

KW - psoriasis

KW - remission

KW - skin clearance

KW - systemics

KW - topicals

KW - treatment discontinuation

U2 - 10.1016/j.jaad.2023.01.029

DO - 10.1016/j.jaad.2023.01.029

M3 - Journal article

C2 - 36739903

SN - 0190-9622

VL - 88

SP - 1378

EP - 1381

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 6

ER -